📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension. (2012)

First Author: Hameed AG

Attributed to: Centre for Integrative Physiology and Pharmacology at Imperial funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1084/jem.20112716

PubMed Identifier: 23071256

Publication URI: http://europepmc.org/abstract/MED/23071256

Type: Journal Article/Review

Volume: 209

Parent Publication: The Journal of experimental medicine

Issue: 11

ISSN: 0022-1007